NCT00010192 2013-06-06Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed30 enrolled
NCT00002649 2013-02-28Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 3 Completed206 enrolled